Frumovitz M, Chisholm GB, Jhingran A, Ramalingam P, et al. Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study. Am J Obstet Gynecol 2023;228:445.
PMID: 36516952